Trial Profile
Efficacy and Safety of Different Dose of Tirofiban in Interventional Treatment of Complex Coronary Artery Disease
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Tirofiban (Primary)
- Indications Acute coronary syndromes; Coronary artery disease; Coronary thrombosis; Unstable angina pectoris
- Focus Adverse reactions
- 01 Dec 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 25 Nov 2014 New trial record